- Poster presentation
- Open Access
Experience in recruiting youths in HIV vaccine trials in Tanzania: the TaMoVac 01 study
Retrovirology volume 9, Article number: P125 (2012)
Muhimbili University of Health Allied Science has been conducting HIV Vaccine trials since 2007. The first trial the HIVIS 03 study began in February 2007 that recruited Police. We believe that the population to be prevented from HIV would be youths. We describe our experice in recruiting youths.
Sensitization meetings were conducted at the youth clinic.Pre screening workshops were conducted at Muhimbili National Hospital. Youths who showed interest in volunteering were asked to come for screening at the clinic located at Muhimbili National Hospital.
Enrolment of youth volunteers in the study was not a problem. Among 60 volunteers recruited 25 were youths. We recruited 5 males and 20 females who were recruited over 1 year. There were challenges encountered in recruiting youths. These included inability for independent decision to join the trail though we noted that the parents were supportive after being well informed. 4/25 youths relocated in search for jobs this resulted in additional costs to call in the volunteer for safety assessments. 2/25 female youths became pregnant during the study period.
We noted that it was easy to recruit youths in the trial after the parents were well informed. However, there is need for continuous education so as to address pregnancy prevention.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Massawa, T., Swalehe, A. & Niima, D. Experience in recruiting youths in HIV vaccine trials in Tanzania: the TaMoVac 01 study. Retrovirology 9 (Suppl 2), P125 (2012). https://doi.org/10.1186/1742-4690-9-S2-P125
- Infectious Disease
- Cancer Research
- Additional Cost
- Safety Assessment
- National Hospital